Clinical trials
Completed Phase 2 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,708 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 18 |
| 2001 | 26 |
| 2002 | 55 |
| 2003 | 53 |
| 2004 | 82 |
| 2005 | 92 |
| 2006 | 97 |
| 2007 | 138 |
| 2008 | 153 |
| 2009 | 170 |
| 2010 | 149 |
| 2011 | 171 |
| 2012 | 158 |
| 2013 | 136 |
| 2014 | 137 |
| 2015 | 166 |
| 2016 | 118 |
| 2017 | 139 |
| 2018 | 115 |
| 2019 | 132 |
| 2020 | 104 |
| 2021 | 104 |
| 2022 | 74 |
| 2023 | 38 |
| 2024 | 31 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,708 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 129 |
| Assistance Publique - Hôpitaux de Paris | 102 |
| Hoffmann-La Roche | 101 |
| Bristol-Myers Squibb | 78 |
| GlaxoSmithKline | 77 |
| Sanofi | 71 |
| Boehringer Ingelheim | 58 |
| Pfizer | 57 |
| European Organisation for Research and Treatment of Cancer - EORTC | 56 |
| AstraZeneca | 55 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 145 |
| Carcinoma, Non-Small-Cell Lung | 112 |
| Neoplasm Metastasis | 86 |
| Neoplasms | 80 |
| Colorectal Neoplasms | 67 |
| Recurrence | 63 |
| Multiple Myeloma | 46 |
| HIV Infections | 43 |
| Lymphoma | 43 |
| Melanoma | 43 |
Trials
Showing 1 to 25 of 2,708. Each trial links to its page on Pharma Observatory.
2,608 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.